
Dual Antiplatelet Therapy vs Alteplase for Patients With Acute Ischemic Stroke
Neurology® Podcast
00:00
Introduction
Neurology podcast provides practical information to neurologists and other clinicians. Outcomes for patients with NMDA receptor encephalitis have not changed over the last decade. NIH sponsored extinguish trial is now enrolling new NMDA receptorEncephalitis patients. Tan Nguyen from Boston University talks about her paper titled Dual Antiplate with Therapy versus All to Plays for Patients with Non-Disabling Acute Aschemic Stroke.
Transcript
Play full episode